Globalink Restates 2024 Financials, Cites Redemption Overpayment Error

TL;DR

**Globalink's restatement signals sloppy accounting and a material weakness in controls, making it a risky bet for investors.**

AI Summary

GLOBALINK INVESTMENT INC. (Globalink) filed a 10-K/A on August 22, 2025, to amend and restate its financial statements for the fiscal year ended December 31, 2024. The restatement was necessary due to an overpayment of $0.24643075 per share to stockholders who redeemed their shares at the December 3, 2024 Extension Meeting, totaling 2,285,056 shares. This overpayment occurred because the company did not withdraw all permitted interest from the trust account for income and franchise taxes, leading to an incorrect per-share redemption price. The original filing incorrectly adjusted the common stock subject to possible redemption to reflect the initial public offering's principal per share price of $10.15, without considering additional extension payments and interest. Management identified a material weakness in internal control over financial reporting related to calculating and reporting common stock subject to possible redemption and reviewing the redemption price per share. The company's IPO on December 9, 2021, raised $100,000,000 from 10,000,000 units, with an additional $15,000,000 from 1,500,000 Over-Allotment Units, and $5,700,000 from private placements. A total of $116,725,000 was placed in the Trust Account, initially at $10.15 per unit. As of March 24, 2025, there were 3,722,511 shares of common stock outstanding, with an aggregate market value of approximately $29.09 million as of June 30, 2024.

Why It Matters

This restatement reveals a critical internal control weakness at Globalink, specifically concerning the accurate calculation of redemption prices and trust account management. For investors, this highlights operational risks and potential misstatements in financial reporting, impacting confidence in the company's financial integrity. The overpayment of $0.24643075 per share to December 2024 Extension Redeeming Stockholders, while seemingly small, indicates a systemic issue in financial controls that could affect future shareholder actions or business combinations. Competitively, such errors can erode trust, making it harder for Globalink to attract partners or complete its initial business combination, especially in the medical technology and green energy sectors it targets.

Risk Assessment

Risk Level: high — The filing explicitly states a 'material weakness exists in the Company's internal control over financial reporting related to the Company's calculating and reporting of the common stock subject to possible redemption and the review of the redemption price per share.' This material weakness, evidenced by the $0.24643075 per share overpayment to 2,285,056 redeeming stockholders in December 2024, indicates a significant deficiency that could lead to future material misstatements in financial reporting.

Analyst Insight

Investors should exercise extreme caution and thoroughly scrutinize Globalink's future filings and internal control improvements. Given the identified material weakness, consider delaying any investment decisions until the company demonstrates robust remediation of its financial reporting controls and provides clear evidence of accurate redemption calculations.

Financial Highlights

debt To Equity

Not Disclosed

revenue

Not Disclosed

operating Margin

Not Disclosed

total Assets

Not Disclosed

total Debt

Not Disclosed

net Income

Not Disclosed

eps

Not Disclosed

gross Margin

Not Disclosed

cash Position

$116,725,000

revenue Growth

Not Disclosed

Key Numbers

• $0.24643075 — Overpayment per share (Amount overpaid to redeeming stockholders in December 2024)
• 2,285,056 — Shares redeemed (Number of shares redeemed at the December 2024 Extension Meeting)
• $11.76793003 — Actual redemption payment per share (Rate paid to December 2024 Extension Redeeming Stockholders)
• $11.52149928 — Corrected redemption payment per share (Approximate correct redemption rate per share)
• $10.15 — Principal per share price (Reported at initial public offering)
• $116,725,000 — Total funds in Trust Account (Net proceeds from IPO and private placements)
• 3,722,511 — Shares outstanding (As of March 24, 2025)
• $29.09 million — Market value of non-affiliate common stock (As of June 30, 2024)
• 6,756,695 — Shares redeemed in March 2023 (For approximately $69.92 million)
• $1.17 million — Aggregate extension deposits (Deposited into Trust Account from March to December 2023)

Key Players & Entities

• GLOBALINK INVESTMENT INC. (company) — registrant filing 10-K/A
• SEC (regulator) — U.S. Securities and Exchange Commission
• Continental Stock & Transfer Company (company) — trustee of the trust account
• Alps Holdco (company) — merger agreement counterparty
• Mr. Cliff (Ming Hang) Chong (person) — former Chief Financial Officer and director
• Mr. Kelvin (Zeng Yenn) Chin (person) — appointed Chief Financial Officer and director
• GL Sponsor LLC (company) — sponsor of Globalink
• Public Gold Marketing Sdn. Bhd (company) — private investor (PGM)
• $0.24643075 (dollar_amount) — December 2024 Extension Overpayment Amount per share
• $29.09 million (dollar_amount) — aggregate market value of common stock held by non-affiliates as of June 30, 2024

FAQ

Risk Factors

• Trust Account Overpayment Risk [high — financial]: The company experienced a material weakness in internal controls leading to an overpayment of $0.24643075 per share to 2,285,056 redeeming stockholders. This resulted in a restatement of financial statements and highlights a risk in the accuracy of financial calculations, particularly concerning the redemption price per share.
• Internal Control Deficiencies [high — operational]: A material weakness was identified in the calculation and reporting of common stock subject to possible redemption and the review of the redemption price per share. This indicates a significant deficiency in the company's internal control environment, potentially impacting the reliability of financial reporting.
• Dependence on Trust Account Management [medium — financial]: The company's operations are heavily reliant on the proper management of its trust account. The overpayment incident stemmed from not withdrawing all permitted interest for taxes, demonstrating a vulnerability in managing these funds and adhering to withdrawal protocols.
• Market Volatility and Share Value [medium — market]: As of June 30, 2024, the market value of non-affiliate common stock was approximately $29.09 million, a significant decrease from the IPO proceeds. This highlights the market's perception and the inherent volatility of the company's stock.

Industry Context

Globalink Investment Inc. operates within the financial services sector, likely as a Special Purpose Acquisition Company (SPAC) given the structure of its IPO and trust account. The SPAC market has faced increased scrutiny and volatility, with many companies struggling to complete business combinations or facing redemption pressures from shareholders.

Regulatory Implications

The restatement and identification of a material weakness highlight potential SEC scrutiny regarding internal controls and financial reporting accuracy. Companies in this sector must ensure robust processes for calculating redemption prices and managing trust accounts to avoid compliance issues.

What Investors Should Do

1. Review the restated financial statements carefully.
2. Assess the company's internal control remediation plan.
3. Monitor future redemption activity and trust account management.

Key Dates

• 2021-12-09: Initial Public Offering (IPO) — Raised $100,000,000 from 10,000,000 units, plus additional funds from over-allotment and private placements, totaling $116,725,000 placed in the Trust Account.
• 2024-12-03: Extension Meeting — Stockholders redeemed shares at an incorrect per-share price due to an overpayment, necessitating a financial restatement.
• 2025-08-22: 10-K/A Filing — Amended and restated financial statements for the fiscal year ended December 31, 2024, to correct the overpayment to redeeming stockholders.

Glossary

Trust Account

A segregated account holding funds raised from an IPO, typically used by special purpose acquisition companies (SPACs) to fund a business combination. (The company's IPO proceeds of $116,725,000 were initially placed in the Trust Account, and its management is critical to financial operations.)

Common Stock Subject to Possible Redemption

Represents shares that holders have the right to redeem for cash, usually at a specified price, often tied to the IPO price plus interest. (Incorrect calculation and reporting of this category led to a material weakness and financial restatement due to an overpayment of $0.24643075 per share.)

Material Weakness

A deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of the company's annual or interim financial statements will not be prevented or detected on a timely basis. (The company identified a material weakness related to the calculation and review of redemption prices, leading to the restatement.)

10-K/A

An amended annual report filed with the SEC to correct or supplement information previously reported in a Form 10-K. (Globalink filed a 10-K/A on August 22, 2025, to restate its 2024 financial statements due to an overpayment error.)

Year-Over-Year Comparison

The primary difference from the previous filing is the restatement of financial statements for the fiscal year ended December 31, 2024, due to a material overpayment to redeeming stockholders. This restatement corrects the calculation of common stock subject to redemption and the per-share redemption price, addressing a previously identified material weakness in internal controls.

Key Financial Figures

• $0.001 — he registrant's common stock, par value $0.001 per share, held by non-affiliates of th
• $11.76793003 — ion Redeeming Stockholders at a rate of $11.76793003 per share ("the "December 2024 Redempti
• $11.52149928 — Payment should have been approximately $11.52149928 per share. This meant that the December
• $0.24643075 — kholders were overpaid in the amount of $0.24643075 per share (the "December 2024 Extension
• $10.15 — er share redemption price was below the $10.15 ("principal per share price") reported
• $11.50 — f a share of common stock at a price of $11.50 per whole share. The units were sold at
• $10.00 — units were sold at an offering price of $10.00 per unit, generating gross proceeds of
• $100,000,000 — per unit, generating gross proceeds of $100,000,000. Simultaneously with the closing of the
• $5,175,000 — per unit, generating total proceeds of $5,175,000. On December 9, 2021, the underwriter
• $15,000,000 — nit resulted in total gross proceeds of $15,000,000. On December 13, 2021, simultaneously w
• $525,000 — ate units, generating gross proceeds of $525,000. The private units were issued pursuant
• $116,725,000 — involve a public offering. A total of $116,725,000 of the net proceeds from the sale of un
• $390,000 — line applicable prior to the extension, $390,000 for each three-month extension and $130
• $130,000 — ,000 for each three-month extension and $130,000 for each one-month extension. On March
• $10.35 — res for cash at an approximate price of $10.35 per share, for an aggregate of approxim

Filing Documents

• form10-ka.htm (10-K/A) — 1612KB
• ex31-1.htm (EX-31.1) — 19KB
• ex31-2.htm (EX-31.2) — 19KB
• ex32-1.htm (EX-32.1) — 8KB
• ex32-2.htm (EX-32.2) — 8KB
• 0001641172-25-025118.txt ( ) — 6218KB
• glli-20241231.xsd (EX-101.SCH) — 43KB
• glli-20241231_cal.xml (EX-101.CAL) — 52KB
• glli-20241231_def.xml (EX-101.DEF) — 180KB
• glli-20241231_lab.xml (EX-101.LAB) — 384KB
• glli-20241231_pre.xml (EX-101.PRE) — 308KB
• form10-ka_htm.xml (XML) — 741KB

Business

Business 5 Item 1A.

Risk Factors

Risk Factors 28 Item 1B. Unresolved Staff Comments 47 Item 1C. Cybersecurity 47 Item 2.

Properties

Properties 48 Item 3.

Legal Proceedings

Legal Proceedings 48 Item 4. Mine Safety Disclosures 48 PART II Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 48 Item 6. [Reserved] 49 Item 7.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 49 Item 7A.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 57 Item 8.

Financial Statements and Supplementary Data

Financial Statements and Supplementary Data 57 Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 57 Item 9A.

Controls and Procedures

Controls and Procedures 58 Item 9B. Other Information 59 Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections 59 PART III Item 10. Directors, Executive Officers and Corporate Governance 59 Item 11.

Executive Compensation

Executive Compensation 65 Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 65 Item 13. Certain Relationships and Related Transactions, and Director Independence 67 Item 14. Principal Accountant Fees and Services 68 PART IV Item 15. Exhibits and Financial Statement Schedules 69 Item 16. Form 10-K Summary 70

SIGNATURES

SIGNATURES 71 2 EXPLANATORY NOTE Globalink Investment Inc. (the "Company," "we", "our" or "us") is filing this Amendment No. 1 (this "Amendment") to the Annual Report on Form 10-K for the year ended December 31, 2024, originally filed with the U.S. Securities and Exchange Commission (the "SEC") on March 25, 2025 (the "Original Filing," as amended by this Amendment, the "Annual Report"), as a comprehensive amendment to amend and restate its financial statements and related footnote disclosures included in the Original Filing as of and for the period ended December 31, 2024. Background of Restatement On December 3, 2024, the Company held a special meeting of its stockholders (the "December 2024 Extension Meeting"). In connection with the December 2024 Extension Meeting, as set forth in the Company's Report on Form 8-K filed with the SEC on December 6, 2024, the holders of 2,285,056 shares of the Company's common stock properly exercised their right to redeem (the "December 2024 Extension Redeeming Stockholders") such shares for a pro rata portion of the funds in the Company's trust account. On December 11, 2024, a redemption payment was made by Continental Stock & Transfer Company ("CST"), as trustee of the trust account, to the December 2024 Extension Redeeming Stockholders at a rate of $11.76793003 per share ("the "December 2024 Redemption Payment"). It was later determined that the Company did not withdrawal all of the interest from the trust account that was permitted to withdrawal to cover income and franchise taxes and, therefore, the December 2024 Redemption Payment should have been approximately $11.52149928 per share. This meant that the December 2024 Extension Redeeming Stockholders were overpaid in the amount of $0.24643075 per share (the "December 2024 Extension Overpayment Amount"). As a result of the December 2024 Extension Overpayment Amount, the Company lacked the available amounts of interest in the trust account to fully cover the permit

View Full Filing

View this 10-K/A filing on SEC EDGAR